LAMEA Continuous Glucose Monitoring Systems (CGMS) Market

LAMEA Continuous Glucose Monitoring Systems (CGMS) Market Overview

The LAMEA Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 34.2% during 2016 -2022.

The increased and ongoing efforts of ‘patient-education’ and ‘screening for diabetes’ programs would increase the awareness levels and eventually would drive the overall diabetes treatment and management market growth. Significantly growing purchasing power among the end-user/patient base in the developing and underdeveloped regions would act as a major factor driving the market during the forecast period.

The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years. Bionic pancreas is another notable product which is a smart and a complete diabetes management solution which is majorly used for Type I diabetes patients, is another notable breakthrough within the CGMS market.

LAMEA Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

The report highlights the adoption of Continuous Glucose Monitoring Systems in LAMEA.Based on the Component, the LAMEA Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.

LAMEA Continuous Glucose Monitoring Systems (CGMS) Market Key Companies

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Research Scope

The market is segmented based on Component, End User and Country.

LAMEA Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

LAMEA Continuous Glucose Monitoring Systems Market, by Component

• Hardware
• Software
• Services

LAMEA Continuous Glucose Monitoring Systems Market, by End User

• Displays Terminals
• Interface Software
• Industrial PCs
• Other Controllers

LAMEA Continuous Glucose Monitoring Systems Market, by Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Company Profiles

• Roche Diagnostics
• Abbott Laboratories
• Dexcom Inc.
• Novo Nordisk
• Ypsomed AG
• GlySens Incorporated
• Medtronic Plc and
• Johnson & Johnson

Unique Offerings from KBV Research

• Exhaustive coverage of LAMEA Continuous Glucose Monitoring Systems (CGMS) Market
• Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
• Subscription based model available
• Free of cost quarterly updates
• Free of cost automatic pdf report generation
• Guaranteed best price
• Assured post sales research support with 10% customization free

Chapter 1-Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  LAMEA Continuous Glucose Monitoring Systems Market, by Component

1.4.2  LAMEA Continuous Glucose Monitoring Systems Market, by End User

1.4.3  LAMEA Continuous Glucose Monitoring Systems Market, by Country

1.5  Methodology for the research

Chapter 2.  Market Overview

2.1  Introduction

2.2  Key Influencing Factors

2.2.1  Drivers

2.2.2  Restraints

2.2.3  Opportunities

2.3  LAMEA Continuous Glucose Monitoring Systems Market – By Component

2.4  LAMEA Continuous Glucose Monitoring Systems Market – By End User

Chapter 3.  LAMEA Continuous Glucose Monitoring Systems Market – By Component

3.1  LAMEA Continuous Glucose Monitoring Systems Sensors Market – By Country

3.2  LAMEA Continuous Glucose Monitoring Transmitters & Receivers Market – By Country

3.3  LAMEA Continuous Glucose Monitoring Systems Integrated Insulin pumps Market – By Country

Chapter 4.  LAMEA Continuous Glucose Monitoring Systems Market – By End User

4.1  LAMEA Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market – By Country

4.2  LAMEA ICUs Continuous Glucose Monitoring Systems Market – By Country

4.3  LAMEA Home Healthcare Continuous Glucose Monitoring Systems Market – By Country

Chapter 5.  LAMEA Continuous Glucose Monitoring Systems Market – By Country

5.1  Brazil Continuous Glucose Monitoring Systems Market

5.1.1  Brazil Continuous Glucose Monitoring Systems Market – By Component

5.1.2  Brazil Continuous Glucose Monitoring Systems Market – By End User

5.2  Argentina Continuous Glucose Monitoring Systems Market

5.2.1  Argentina Continuous Glucose Monitoring Systems Market – By Component

5.2.2  Argentina Continuous Glucose Monitoring Systems Market – By End User

5.3  UAE Continuous Glucose Monitoring Systems Market

5.3.1  UAE Continuous Glucose Monitoring Systems Market – By Component

5.3.2  UAE Continuous Glucose Monitoring Systems Market – By End User

5.4  Saudi Arabia Continuous Glucose Monitoring Systems Market

5.4.1  Saudi Arabia Continuous Glucose Monitoring Systems Market – By Component

5.4.2  Saudi Arabia Continuous Glucose Monitoring Systems Market – By End User

5.5  South Africa Continuous Glucose Monitoring Systems Market

5.5.1  South Africa Continuous Glucose Monitoring Systems Market – By Component

5.5.2  South Africa Continuous Glucose Monitoring Systems Market – By End User

5.6  Nigeria Continuous Glucose Monitoring Systems Market

5.6.1  Nigeria Continuous Glucose Monitoring Systems Market – By Component

5.6.2  Nigeria Continuous Glucose Monitoring Systems Market – By End User

5.7  Rest of LAMEA Continuous Glucose Monitoring Systems Market

5.7.1  Rest of LAMEA Continuous Glucose Monitoring Systems Market – By Component

5.7.2  Rest of LAMEA Continuous Glucose Monitoring Systems Market – By End User

Chapter 6.  Company Profile

6.1  Roche Diagnostics.

6.1.1  Company Overview

6.1.2  Financial Analysis

6.1.3  Segmental Analysis

6.1.4  Research & Development Analysis

6.2  Abbott Laboratories

6.2.1  Company Overview

6.2.2  Financial Analysis

6.2.3  Segmental Analysis

6.2.4  Research & Development Analysis

6.3  Dexcom, Inc.

6.3.1  Company Overview

6.3.2  Financial Analysis

6.3.3  Research & Development Analysis

6.4  Novo Nordisk.

6.4.1  Company Overview

6.4.2  Financial Analysis

6.4.3  Segmental Analysis

6.4.4  Research & Development Analysis

6.5  Ypsomed AG

6.5.1  Company Overview

6.5.2  Financial Analysis

6.5.3  Segmental Analysis

6.6  GlySens Incorporated.

6.6.1  Company Overview

6.7  Medtronic Plc

6.7.1  Company Overview

6.7.2  Financial Analysis

6.7.3  Segmental Analysis

6.7.4  Research & Development Analysis

6.8  Johnson & Johnson.

6.8.1  Company Overview

6.8.2  Financial Analysis

6.8.3  Research & Development Analysis

6.8.4  Segmental Analysis

List of Tables

TABLE 1  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 2  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 3  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 4  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 5  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 6  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 7  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 8  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 9  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 10  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 11  LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 12  LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 13  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 14  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 15  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 16  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 17  LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 18  LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 19  LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 20  LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 21  LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 22  LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 23  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 24  LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 25  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 26  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 27  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 28  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 29  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 30  BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 31  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 32  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 33  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 34  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 35  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 36  ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 37  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 38  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 39  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 40  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 41  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 42  UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 43  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 44  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 45  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 46  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 47  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 48  SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 49  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 50  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 51  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 52  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 53  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 54  SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 55  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 56  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 57  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 58  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 59  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 60  NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 61  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 62  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 63  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 64  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 65  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 66  REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 67  KEY INFORMATION – ROCHE DIAGNOSTICS.

TABLE 68  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 69  KEY INFORMATION – DEXCOM, INC.

TABLE 70  KEY INFORMATION – NOVO NORDISK.

TABLE 71  KEY INFORMATION – YPSOMED AG.

TABLE 72  KEY INFORMATION – GLYSENS INCORPORATED.

TABLE 73  KEY INFORMATION – MEDTRONIC PLC

TABLE 74  KEY INFORMATION – JOHNSON & JOHNSON.